David Alan Campbell Janux Therapeutics, Inc. (JANX) insider trading activity

JANX Quotes by TradingView

David Alan Campbell is President and CEO of Janux Therapeutics, Inc.. Currently has a direct ownership of 242,054 shares of JANX, which is worth approximately $13.6 Million. The most recent transaction as insider was on Dec 03, 2024, when has been sold 15,000 shares (Common Stock) at a price of $67.0 per share, resulting in proceeds of $1,005,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 242K
n/a 3M change
n/a 12M change
Total Value Held $13.6 Million

David Alan Campbell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 03 2024
SELL
Open market or private sale
$1,005,000 $67.0 p/Share
15,000 Reduced 5.84%
242,054 Common Stock
Nov 25 2024
SELL
Open market or private sale
$1,293,500 $51.74 p/Share
25,000 Reduced 8.86%
257,054 Common Stock
Oct 28 2024
SELL
Open market or private sale
$1,339,500 $53.58 p/Share
25,000 Reduced 8.14%
282,054 Common Stock
Sep 27 2024
SELL
Open market or private sale
$1,173,250 $46.93 p/Share
25,000 Reduced 7.53%
307,054 Common Stock
DAC

David Alan Campbell

President and CEO
La Jolla, CA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JANX